Welcome to the latest edition of our Healthcare & Life Sciences Market Update, in which we explore the evolving landscape of investment trends, regulatory challenges, and strategic opportunities shaping the global market.
In this edition, we examine the cautious optimism permeating the healthcare and life sciences industry. As economic stability improves and interest rates decline, the rapid evolution of artificial intelligence (AI) and digital technologies promises transformative change. We anticipate an upturn in M&A activity in 2025, driven by the pharmaceutical industry’s need for portfolio replenishment and the pent-up desire for new assets.
Please see full publication below for more information.
